CMBA
HIMS icon

C.M. Bidwell & Associates’s Hims & Hers Health HIMS Stock Holding History

C.M. Bidwell & Associates’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31
Closed -$626 – 527
2024
Q2 		$626 Buy
+31
New +$516 ﹤0.01% 430

Other funds holding HIMS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IVMX
Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

C.M. Bidwell & Associates's HIMS Position: Q3 2024 in Review

C.M. Bidwell & Associates sold out of Hims & Hers Health (HIMS) in Q3 2024, closing a stake of 31 shares — an estimated $626 sold.

C.M. Bidwell & Associates first reported a position in HIMS in Q2 2024 and held it in 1 quarter. The position peaked at $626 in Q2 2024. 308 funds tracked by Wall St. Rank hold HIMS as of Q3 2024.

  • C.M. Bidwell & Associates reported no remaining Hims & Hers Health position as of Q3 2024 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 31 Hims & Hers Health shares in Q3 2024, an estimated $626.
  • C.M. Bidwell & Associates first reported a position in Hims & Hers Health in Q2 2024 and held it in 1 quarter.
  • C.M. Bidwell & Associates's Hims & Hers Health position peaked at $626 in Q2 2024.
  • 308 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2024.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2024, filed 13 Nov 2024.